False Claims Act Insights - Railroaded! How to Approach the Twin Tracks of Parallel Proceedings
Discretionary Denials at the PTAB: What to Expect? - Patents: Post-Grant Podcast
JONES DAY TALKS®: CFTC and DOJ Target Derivatives Trading Across Industries
Jones Day Talks®: Patent Litigation, PTAB, Iancu's Legacy, and Institution Discretion
The Patent Trial and Appeal Board’s (“PTAB’s”) authority to exercise discretion over whether to institute Inter Partes Review (“IPR”) proceedings has become one of the most consequential features of post-grant practice before...more
The US Court of Appeals for the Federal Circuit affirmed a decision by the Patent Trial & Appeal Board, concluding that inter partes review (IPR) estoppel under 35 U.S.C. § 315(e)(1) does not apply to ongoing ex parte...more
The U.S. Patent and Trademark Office (“USPTO”) recently proposed rules governing inter partes review (“IPR”). If adopted, these requirements would...more
The U.S. Patent and Trademark Office published a notice of proposed rulemaking on October 16, 2025, titled “Revision to Rules of Practice Before the Patent Trial and Appeal Board” announcing its intention to modify the rules...more
The Director of the United States Patent and Trademark Office (USPTO) vacated a Patent Trial & Appeal Board decision instituting an inter partes review (IPR) proceeding after finding that the petitioner advanced inconsistent...more
This week’s unsealing in Boston of a superseding indictment charging eight defendants in an alleged insider trading ring spanning multiple continents marks the latest in a string of prosecutions and SEC enforcement actions...more
On October 17, 2025, the USPTO issued a notice of proposed rulemaking (“Notice”) regarding the rules of practice for inter partes review before the PTAB. The proposed rules do not apply to post grant review petitions,...more
United States congressional inquiries have become an important instrument to shape policy agendas, test industry practices, influence public opinion, and apply pressure on industries and companies seen as politically...more
On September 29, 2025, the U.S. District Court for the Southern District of New York applied the Colorado River abstention doctrine to dismiss a lender liability action against Computershare Trust Company, National...more
On November 6, 2025, the U.S. Court of Appeals for the Federal Circuit (Judges Dyk, Linn, Cunningham, and/or Stoll) issued orders denying three petitions for mandamus (out of seven currently pending) challenging then-Acting...more
Are you planning on challenging a competitor’s patent at the US Patent and Trademark Office (USPTO)? The policies of the new director of the USPTO may cause you to rethink your strategy. The USPTO has recently proposed a new...more
In a March 2025 article, we provided strategy considerations for both parties handling ex parte reexaminations following denied inter partes reviews (IPRs) in view of the United States Patent and Trademark Office (USPTO)...more
In a recent decision, Acting Director Coke Morgan Stewart granted Patent Owner’s request for discretionary denial in Sun Pharmaceuticals Industries Inc. v. Nivagen Pharmaceuticals, Inc., IPR2025-00893. While some factors...more
On October 17, 2025, the USPTO proposed new rules that would dramatically alter IPR strategy. The most impactful change to the status quo is a proposal to bar the PTAB from instituting an IPR if a parallel district court case...more
The United States Patent and Trademark Office (USPTO) proposed changes to the rules governing inter partes reviews (IPRs) before the Patent Trial & Appeal Board, including setting limits on use of IPR proceedings for patent...more
The U.S. Patent and Trademark Office (USPTO) has announced proposed rulemaking that could fundamentally reshape the Inter Partes Review (IPR) landscape. The proposal aims to make invalidity a “one-and-done” process,...more
On September 16, 2025, acting USPTO Director Coke Morgan Stewart released a memo instructing the Patent Trial and Appeal Board (PTAB) that if the Board is considering claims that have “already been adjudicated” before the...more
The output of new enforcement actions from the Commodity Future Trading Commission (CFTC) has virtually ground to a halt in 2025, with a slowdown that greatly exceeds the slower pace of new Securities and Exchange Commission...more
Federal Government of Nigeria & Anor v Louis Emovbira Williams [2025] EWHC 2217 (Comm) - Summary - In what is understood to be the first reported case of its kind, the English High Court has granted an...more
For the first time under the bifurcated institution procedures, the Acting Director reversed her own prior discretionary denial, citing changed circumstances based on a settlement in the parallel district court litigation. ...more
On December 6, 2024, Comcast Cable Communications, LLC (“Comcast”) filed three separate petitions for inter partes review (“IPR”) of U.S. Patent No. 9,866,438 (“the ’438 Patent”), which is assigned to Entropic Communications,...more
On July 24, 2025, Acting Director of the USPTO, Coke Morgan Stewart, denied institution of inter partes review in IPR2025-00601 and IPR2025-00602, but referred the petition in IPR2025-00603 to the Board in Amgen Inc. v....more
The first half of 2025 has brought many changes at the United States Patent and Trademark Office (“USPTO”), including policy changes at the Patent Trial and Appeal Board (“PTAB”). At the end of March 2025, the issuance of the...more
There has not been much news regarding SEC enforcement lately, but today the SEC and DOJ both charged a founder of a Washington-based water vending machine manufacturer Water Station Management, LLC and two related companies...more
Back in 2009, Salvador Parra filed suit in the trial court of Jones County, Mississippi against 19 companies for asbestos exposure. He amended to clarify he was a Louisiana citizen but was employed in Mississippi in 1968-69...more